Most compounded versions of popular drugs used for weight loss including Wegovy and Zepbound may soon no longer be available after a U.S. judge declined an initial injunction to allow compounding ...

Lawsuit alleges anti-competitive conduct designed to suppress lawful compounding pharmaceuticals and limit patient choice ...

Custom formulations of popular weight loss medications have surged in popularity due to the high costs of FDA-approved drugs.

May 29—(StatePoint) Most consumers know how a traditional pharmacy works. Far fewer are aware of an alternative option: a compounding pharmacy. Here's everything you need to know about these ...

It is easy to differentiate between your local community pharmacy and a large pharmaceutical manufacturer. The pharmacy is viewed as dispensing medications to particular patients with prescriptions ...

The Food and Drug Administration announced that branded tirzepatide, the active ingredient in Eli Lilly's weight loss drug Zepbound, is no longer in short supply. That decision will largely prevent ...

(ProRx Pharma) - From hospitals to surgical centers, med spas to even your dentist’s office—chances are, you or someone in your family has already received medication from a compounding pharmacy ...

Compounding pharmacy sues Eli Lilly and Novo Nordisk alleging antitrust violations to restrict compounded GLP-1 medication access and limit competition.

Pete Pharma, a leader in pharmaceutical innovation and pharmaceutical IP development, is proud to announce a strategic ...

Strive Compounding Pharmacy sues Eli Lilly and Novo Nordisk over alleged GLP-1 weight loss drug competition limits. Read more ...

Navvi, the leading digital prescription marketplace, today announced a strategic partnership with SandsRx, adding one of Texas's most respected independent pharmacies to its growing network. This ...